Jeremy Meier

Jeremy Meier is an Assistant Professor at the University of North Carolina at Chapel Hill School of Medicine, affiliated with the Immunology Department and the Bone Marrow Transplant and Cellular Therapy Program. His research focuses on T-cell signal transduction pathways, mitochondrial function in immune cells, and therapeutic targets for cellular therapeutics in cancer.

• Hematology
• Immunology

Dr. Meier's work explores how extracellular signals regulate mitochondrial function in T-cells, impacting tumor immunity and long-term effectiveness of cellular therapies. He has published extensively on immunometabolism, cancer immunotherapy, and signal transduction mechanisms.

His recent publications highlight trends in tumor microenvironment studies, STAT3 signaling, and lipid metabolism in T-cells. Articles span journals like Cell Metabolism, Science Signaling, and Nature, reflecting interdisciplinary research at the intersection of immunology, oncology, and molecular biology.

Scientific recognition includes:

• 2024 Scholar Award, American Society of Hematology
• 2024 UNC Physician Scientist Faculty Award
• 2023 Pope Clinical Trainee Award
• 2023 Young Investigator Award, American Society of Clinical Oncology
• 2022 Outstanding Fellow Award, North Carolina Oncology Association
• 2014 Ruth L. Kirschstein National Research Service Award

Dr. Meier's contributions to understanding T-cell dynamics in transplantation and cancer therapy are pivotal, with ongoing work targeting mitochondrial pathways for improved immunotherapies.